In conclusion, our study elucidates mechanism that SNHG4 promotes progression of glioma through miR-367-3p/MYO1B axis, which may contribute to find the potential diagnostic and therapeutic target of glioma patients. The gene discussed is MYO1B; the disease is central nervous system cancer.